benzimidazole has been researched along with clarithromycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CS; Chen, LY; Kao, MC; Kuo, SC; Lai, CH; Lin, CD; Lin, HJ; Liu, JF; Lu, DY; Sing, YT; Tang, CH | 1 |
| Haga, K; Hirayama, F; Iwao, E; Yamamoto, K; Yokoyama, Y | 1 |
2 other study(ies) available for benzimidazole and clarithromycin
| Article | Year |
|---|---|
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell Line; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoblotting; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2012 |
Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2004 |